[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE113591T1 - 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. - Google Patents

4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.

Info

Publication number
ATE113591T1
ATE113591T1 AT90124971T AT90124971T ATE113591T1 AT E113591 T1 ATE113591 T1 AT E113591T1 AT 90124971 T AT90124971 T AT 90124971T AT 90124971 T AT90124971 T AT 90124971T AT E113591 T1 ATE113591 T1 AT E113591T1
Authority
AT
Austria
Prior art keywords
anticonvulsants
dihydro
benzyl
phenyl
triazole
Prior art date
Application number
AT90124971T
Other languages
English (en)
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE113591T1 publication Critical patent/ATE113591T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90124971T 1989-12-20 1990-12-20 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. ATE113591T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/453,440 US4966909A (en) 1989-12-20 1989-12-20 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants

Publications (1)

Publication Number Publication Date
ATE113591T1 true ATE113591T1 (de) 1994-11-15

Family

ID=23800598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90124971T ATE113591T1 (de) 1989-12-20 1990-12-20 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.

Country Status (12)

Country Link
US (1) US4966909A (de)
EP (1) EP0435177B1 (de)
JP (1) JP2968053B2 (de)
KR (1) KR0154529B1 (de)
AT (1) ATE113591T1 (de)
AU (1) AU634003B2 (de)
DE (1) DE69013871T2 (de)
DK (1) DK0435177T3 (de)
ES (1) ES2066096T3 (de)
IE (1) IE64989B1 (de)
PH (1) PH27352A (de)
ZA (1) ZA9010080B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
SE470120B (sv) * 1992-04-03 1993-11-08 Whirlpool Int Förfarande för styrning av mikrovågsenergin i en mikrovågsugn och mikrovågsugn för genomförande av förfarandet
CA2216787C (en) * 1995-04-20 2001-05-22 Hoechst Marion Roussel, Inc. 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
US6489487B1 (en) * 1998-08-03 2002-12-03 Sumitomo Chemical Company, Limited Triazolone derivatives, use thereof, and intermediates therefor
US6156775A (en) * 1999-03-01 2000-12-05 Novartis Ag Use of fluorinated triazoles in treating affective and attention disorders
TW200505441A (en) 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
US7400548B2 (en) * 2005-02-09 2008-07-15 International Business Machines Corporation Method for providing multiple reads/writes using a 2read/2write register file array
BRPI0809617A2 (pt) 2007-03-29 2014-09-16 Hoffmann La Roche Inibidores não-nucleosídicos da transcriptase reversa
JP2022189000A (ja) 2021-06-10 2022-12-22 Tmtマシナリー株式会社 紡糸引取装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126882B (de) * 1960-05-03 1962-04-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von 1,2,4-Triazolonen-(5)
BE621842A (de) * 1962-08-27
GB1068083A (en) * 1964-04-02 1967-05-10 Philippe Gold Aubert í¸-1,2,4-triazolone-(5) derivatives
US3621099A (en) * 1969-03-05 1971-11-16 Charles R Jacobson Therapeutic compositions and methods for stimulating the central nervous system
DE3173083D1 (en) * 1980-03-22 1986-01-16 Fbc Ltd Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use
DD153953A3 (de) * 1980-04-01 1982-02-17 Gottfried Schuster Mittel zur chemotherapie von virosen der kulturpflanzen
DD160447A1 (de) * 1981-03-26 1983-08-03 Johannes Dost Herbizide mittel, die 1,2,4-triazolinone-(5) enthalten
BE894856A (fr) * 1982-10-28 1983-02-14 Fahlberg List Veb Compositions herbicides a base d'un derive de la 1,2,4-triazolinone-(5)
PH24094A (en) * 1986-12-19 1990-03-05 Merrell Dow Pharma 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
JP2593084B2 (ja) * 1986-12-19 1997-03-19 メレルダウファーマスーティカルズ インコーポレーテッド 5−アリールー3h−1,2,4−トリアゾールー3−オン類の神経変性障害の処置への用途
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants

Also Published As

Publication number Publication date
ES2066096T3 (es) 1995-03-01
PH27352A (en) 1993-06-21
DK0435177T3 (da) 1994-11-21
EP0435177A3 (en) 1992-01-08
ZA9010080B (en) 1991-10-30
AU6808190A (en) 1991-06-27
DE69013871D1 (de) 1994-12-08
EP0435177B1 (de) 1994-11-02
KR910011807A (ko) 1991-08-07
IE904599A1 (en) 1991-07-03
JPH04128271A (ja) 1992-04-28
US4966909A (en) 1990-10-30
JP2968053B2 (ja) 1999-10-25
EP0435177A2 (de) 1991-07-03
AU634003B2 (en) 1993-02-11
IE64989B1 (en) 1995-09-20
DE69013871T2 (de) 1995-03-09
KR0154529B1 (ko) 1998-11-16

Similar Documents

Publication Publication Date Title
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
ATE304848T1 (de) Verwendung von vier k-252a derivaten
DE69829412D1 (de) Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
HU9501151D0 (en) Substituted pyridylpyrazoles
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE68925004D1 (de) Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
HK1017684A1 (en) Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases
ATE116851T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung in der behandlung neurodegenerativer beschwerden.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
ATE262307T1 (de) Verwendung von goldlegierungen für konstruktionselemente in der dentaltechnik
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
ATE157654T1 (de) Verwendung von aminoalkyl-substituierten 5,6- dihydro-dibenz(b,e)azepin-6,11-dion-11-oximen als antivirale mittel
DE68906248D1 (de) Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.
ATE247467T1 (de) Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin
ATE78466T1 (de) 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee